Camacho F - Search Results

1

Cholinergic modulation of a decrement in social investigation following repeated contacts between mice.

Winslow JT, Camacho F. Winslow JT, et al. Among authors: camacho f. Psychopharmacology (Berl). 1995 Sep;121(2):164-72. doi: 10.1007/BF02245626. Psychopharmacology (Berl). 1995. PMID: 8545521

2

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM. Smith CP, et al. Among authors: camacho f. J Pharmacol Exp Ther. 1997 Feb;280(2):710-20. J Pharmacol Exp Ther. 1997. PMID: 9023283

3

Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.

Camacho F, Smith CP, Vargas HM, Winslow JT. Camacho F, et al. Psychopharmacology (Berl). 1996 Apr;124(4):347-54. doi: 10.1007/BF02247440. Psychopharmacology (Berl). 1996. PMID: 8739550

4

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW Jr, Davis L, Vargas HM. Bores GM, et al. Among authors: camacho f. J Pharmacol Exp Ther. 1996 May;277(2):728-38. J Pharmacol Exp Ther. 1996. PMID: 8627552

5

Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents.

Dunn RW, Flanagan DM, Martin LL, Kerman LL, Woods AT, Camacho F, Wilmot CA, Cornfeldt ML, Effland RC, Wood PL, et al. Dunn RW, et al. Among authors: camacho f. Eur J Pharmacol. 1992 Apr 22;214(2-3):207-14. doi: 10.1016/0014-2999(92)90120-s. Eur J Pharmacol. 1992. PMID: 1355434

6

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.

Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW. Corbett R, et al. Among authors: camacho f. Psychopharmacology (Berl). 1995 Jul;120(1):67-74. doi: 10.1007/BF02246146. Psychopharmacology (Berl). 1995. PMID: 7480537

7

Phosphorylation and destabilization of human period I clock protein by human casein kinase I epsilon.

Keesler GA, Camacho F, Guo Y, Virshup D, Mondadori C, Yao Z. Keesler GA, et al. Among authors: camacho f. Neuroreport. 2000 Apr 7;11(5):951-5. doi: 10.1097/00001756-200004070-00011. Neuroreport. 2000. PMID: 10790862

8

Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.

Camacho F, Cilio M, Guo Y, Virshup DM, Patel K, Khorkova O, Styren S, Morse B, Yao Z, Keesler GA. Camacho F, et al. FEBS Lett. 2001 Feb 2;489(2-3):159-65. doi: 10.1016/s0014-5793(00)02434-0. FEBS Lett. 2001. PMID: 11165242

9

Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation.

Eide EJ, Woolf MF, Kang H, Woolf P, Hurst W, Camacho F, Vielhaber EL, Giovanni A, Virshup DM. Eide EJ, et al. Among authors: camacho f. Mol Cell Biol. 2005 Apr;25(7):2795-807. doi: 10.1128/MCB.25.7.2795-2807.2005. Mol Cell Biol. 2005. PMID: 15767683 Free PMC article.

10

First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.

Bethea TN, Ochs-Balcom HM, Bandera EV, Beeghly-Fadiel A, Camacho F, Chyn D, Cloyd EK, Harris HR, Joslin CE, Myers E, Moorman PG, Peres LC, Rosenow W, Setiawan VW, Wu AH, Rosenberg L, Schildkraut JM. Bethea TN, et al. Among authors: camacho f. Int J Cancer. 2021 Jan 31. doi: 10.1002/ijc.33493. Online ahead of print. Int J Cancer. 2021. PMID: 33521947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results